Related references
Note: Only part of the references are listed.Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome
Andrea Corrias et al.
CLINICAL ENDOCRINOLOGY (2012)
Prader-Willi Syndrome: Obesity due to Genomic Imprinting
Merlin G. Butler
CURRENT GENOMICS (2012)
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Rasmus Sode-Carlsen et al.
GROWTH HORMONE & IGF RESEARCH (2011)
Effects on Growth and Metabolism of Growth Hormone Treatment for 3 Years in 36 Children with Prader-Willi Syndrome
A. Colmenares et al.
HORMONE RESEARCH IN PAEDIATRICS (2011)
Normal Cortisol Response to High-Dose Synacthen and Insulin Tolerance Test in Children and Adults with Prader-Willi Syndrome
Stense Farholt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The Metabolic Phenotype of Prader-Willi Syndrome (PWS) in Childhood: Heightened Insulin Sensitivity Relative to Body Mass Index
Andrea M. Haqq et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
ADULTS WITH PRADER-WILLI SYNDROME: A SURVEY OF 232 CASES
Louise R. Greenswag
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition: Results from a Randomized, Placebo-Controlled Study
Rasmus Sode-Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Normal Cortisol Response on Low-Dose Synacthen (1 μg) Test in Children with Prader Willi Syndrome
Ohn Nyunt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Long-Term Growth Hormone Therapy Changes the Natural History of Body Composition and Motor Function in Children with Prader-Willi Syndrome
Aaron L. Carrel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Panagiotis Anagnostis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Italian National Survey for Prader-Willi syndrome:: An epidemiologic study
Graziano Grugni et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome
Dederieke A. M. Festen et al.
CLINICAL ENDOCRINOLOGY (2008)
High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome
Roderick F. A. de Lind van Wijngaarden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones
Andrea M. Haqq et al.
CLINICAL ENDOCRINOLOGY (2007)
Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy
D. A. M. Festen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects
L Kennedy et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance
C Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment
T Nagai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Insulin resistance and obesity-related factors in Prader-Willi syndrome: Comparison with obese subjects
Z Talebizadeh et al.
CLINICAL GENETICS (2005)
Growth hormone (GH) replacement therapy in adult-onset GH deficiency: Effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial
AR Hoffman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders
A Vogels et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Prader-Willi syndrome: Causes of death in an international series of 27 cases
CTRM Schrander-Stumpel et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment
C Höybye et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome
AL Carrel et al.
JOURNAL OF PEDIATRICS (2004)
Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children
K Asayama et al.
OBESITY RESEARCH (2003)
New criteria for 'obesity disease' in Japan
Y Matsuzawa et al.
CIRCULATION JOURNAL (2002)
Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study
JV Butler et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2002)
Human growth hormone replacement in adult hypopituitary patients: Long-term effects on body composition and lipid status - 3-year results from the HypoCCS database
AF Attanasio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: Evidence for novel influences on body fat distribution
AP Goldstone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
The hormone resistin links obesity to diabetes
CM Steppan et al.
NATURE (2001)
Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome
D l'Allemend et al.
EUROPEAN JOURNAL OF PEDIATRICS (2000)
Share Paper
